This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Derek Gauntlett
Director, Process Chemistry at Codexis
Speaker

Profile

Mr. Gauntlett joined Codexis in 2023 to oversee process development for the company’s ECO Synthesis™ platform, bringing over 13 years of research and development experience in biotech with a focus in therapeutic modalities, such as enzyme and nucleic acids, from preclinical to commercialization. Prior to joining Codexis, Mr. Gauntlett was pivotal in establishing LGC's rapidly expanding Axolabs division overseeing Chemistry, Manufacturing and Controls group (CMC) of RNA-based therapeutics development. Prior to LGC Axolabs, Mr. Gauntlett worked at BioMarin Pharmaceuticals where he focused on process sciences research and scaled an early-phase drug candidates to commercial production.

Mr. Gauntlett received his B.S. from California State Polytechnic University, Humboldt, and an MBA from Sonoma State University.

Agenda Sessions

  • Enzymatic Oligonucleotide Synthesis Process Flow and Substance Impurity Profile

    12:30pm